-
Views
-
Cite
Cite
T. Littlejohn, R.K. Saini, H. Badiak, M. Beagan, K. Kassler-Taub, S. Freitag, D56: Long-term safety and antihypertensive efficacy of irbesartan, the angiotensin II receptor antagonist: Pooled results of six open-label studies, American Journal of Hypertension, Volume 10, Issue S2, April 1997, Page 119A, https://doi.org/10.1016/S0895-7061(97)89085-1
- Share Icon Share
This content is only available as a PDF.
© American Journal of Hypertension, Ltd. 1997
Issue Section:
Abstracts
You do not currently have access to this article.